J S Newman1, R L Bree, J M Rubin. 1. Department of Radiology, University of Michigan Hospitals, Ann Arbor 48109-0326.
Abstract
PURPOSE: To correlate the findings at prostate color Doppler sonography (CDS) with those of site-specific transrectal core biopsy. MATERIALS AND METHODS: Forty-three patients underwent prostate transrectal ultrasonography (US) and biopsy. CDS was performed at all biopsy sites before US-guided core biopsy. Vascularity at CDS was prospectively graded on a scale of 0-2 (0 = no visible peripheral zone [PZ] flow, 2 = markedly increased PZ vascularity). CDS results were correlated with histologic findings from 220 separate biopsy sites that included 27 focal lesions. RESULTS: Of 34 grade 2 biopsy sites, 21 revealed carcinoma, eight revealed prostatitis, and five were negative. CDS depicted at least one focus of carcinoma in seven patients with no gray-scale abnormality. CDS had a sensitivity of 49%, specificity of 93%, and positive predictive value of 62%. CONCLUSION: Focal PZ hypervascularity at CDS is associated with an increased likelihood of prostate cancer or inflammation at biopsy, often without a focal gray-scale abnormality. CDS may help identify an appropriate site for biopsy. A negative CDS scan, however, should not preclude biopsy, as CDS has a limited sensitivity in the detection of all sites of cancer.
PURPOSE: To correlate the findings at prostate color Doppler sonography (CDS) with those of site-specific transrectal core biopsy. MATERIALS AND METHODS: Forty-three patients underwent prostate transrectal ultrasonography (US) and biopsy. CDS was performed at all biopsy sites before US-guided core biopsy. Vascularity at CDS was prospectively graded on a scale of 0-2 (0 = no visible peripheral zone [PZ] flow, 2 = markedly increased PZ vascularity). CDS results were correlated with histologic findings from 220 separate biopsy sites that included 27 focal lesions. RESULTS: Of 34 grade 2 biopsy sites, 21 revealed carcinoma, eight revealed prostatitis, and five were negative. CDS depicted at least one focus of carcinoma in seven patients with no gray-scale abnormality. CDS had a sensitivity of 49%, specificity of 93%, and positive predictive value of 62%. CONCLUSION: Focal PZ hypervascularity at CDS is associated with an increased likelihood of prostate cancer or inflammation at biopsy, often without a focal gray-scale abnormality. CDS may help identify an appropriate site for biopsy. A negative CDS scan, however, should not preclude biopsy, as CDS has a limited sensitivity in the detection of all sites of cancer.
Authors: Stijn W T P J Heijmink; Hilco van Moerkerk; Lambertus A L M Kiemeney; J Alfred Witjes; Ferdinand Frauscher; Jelle O Barentsz Journal: Eur Radiol Date: 2006-01-04 Impact factor: 5.315
Authors: Gianluigi Taverna; Giorgio Bozzini; Fabio Grizzi; Mauro Seveso; Alberto Mandressi; Luca Balzarini; Federica Mrakic; Pietro Bono; Oliviero De Franceco; NicolòMaria Buffi; Giovanni Lughezzani; Massimo Lazzeri; Paolo Casale; Giorgio Ferruccio Guazzoni Journal: World J Urol Date: 2015-10-19 Impact factor: 4.226
Authors: Luciana R Meirelles; Athanase Billis; Ana C S Cotta; Rui T Nakamura; Nelson M G Caserta; Adilson Prando Journal: Int Urol Nephrol Date: 2002 Impact factor: 2.370
Authors: M Seitz; B Scher; M Scherr; D Tilki; B Schlenker; C Gratzke; A Schipf; P Stanislaus; U Müller-Lisse; O Reich; C Stief Journal: Urologe A Date: 2007-10 Impact factor: 0.639